Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation

Oncogene

Volumn 25, Issue 32, 2006, Pages 4399-4412

  Burnworth, B ^a   Popp, S ^a   Stark, H J ^a   Steinkraus, V ^b   Brocker E B ^c   Hartschuh, W ^d   Birek, C ^e   Boukamp, P ^a,f  

^a Genetics of Skin Carcinogenesis   (Germany)

^b Dermatologicum Hamburg   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF MANITOBA   (Canada)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Aberrant differentiation; cdk4; Keratoacanthoma; p21; Tumorigenicity

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; PROTEIN P21;

ARTICLE; CHROMOSOME 11Q; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EPIDERMIS CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DISRUPTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; KERATOACANTHOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN CANCER; TISSUE DIFFERENTIATION; TUMOR REGRESSION;

ANEUPLOIDY; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 11; CLONE CELLS; COCULTURE TECHNIQUES; CYCLIN D1; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HUMANS; KERATOACANTHOMA; NUCLEIC ACID HYBRIDIZATION; SKIN NEOPLASMS;

EID: 33746524819     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209474     Document Type: Article

References (44)

1. Arnold A, Papanikolaou A. (2005). J Clin Oncol 23: 4215-4224.
2. Ashton KJ, Weinstein SR, Maguire DJ, Griffiths LR. (2003). Arch Dermatol 139: 876-882.
3. Billingsley EM, Davis N, Helm KF. (1999). J Cutan Med Surg 3: 193-197.
4. Boukamp P. (2005). J Dtsch Dermatol Ges 3: 493-503.
5. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. (1988). J Cell Biol 106: 761-771.
6. Boukamp P, Popp S, Altmeyer S, Hulsen A, Fasching C, Cremer T et al. (1997). Genes Chromosomes Cancer 19: 201-214.
7. Boukamp P, Popp S, Bleuel K, Tomakidi E, Burkle A, Fusenig NE. (1999). Oncogene 18: 5638-5645.
8. Boukamp P, Stanbridge EJ, Foo DY, Cerutti PA, Fusenig NE. (1990). Cancer Res 50: 2840-2847.
9. Cerezo A, Stark HJ, Moshir S, Boukamp P. (2003). J Invest Dermatol 121: 110-119.
10. Clausen OP, Beigi M, Bolund L, Kolvraa S, Gjersvik PJ, Mork G et al. (2002). J Invest Dermatol 119: 1367-1372.
11. Di Cunto F, Topley G, Calautti E, Hsiao J, Ong L, Seth PK et al. (1998). Science 280: 1069-1072.
12. Euvrard S, Kanitakis J, Claudy A. (2003). N Engl J Med 348: 1681-1691.
13. Ewen ME, Lamb J. (2004). Trends Mol Med 10: 158-162.
14. Freedberg I, Eisen A, Wolff K, Austen KF, Goldspith L, Katz S et al. (1999). Fitzpatrick's Dermatology in General Medicine. McGraw-Hill Health Professional Division: New York.
15. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. (2004). Endocrinology 145: 5439-5447.
16. Hiyama H, Iavarone A, LaBaer J, Reeves SA. (1997). Oncogene 14: 2533-2542.
17. Hosokawa Y, Arnold A. (1998). Genes Chromosomes Cancer 22: 66-71.
18. Jin Y, Jin C, Salemark L, Wennerberg J, Persson B, Jonsson N. (2002). Cancer Genet Cytogenet 136: 48-52.
19. Jin Y, Martins C, Jin C, Salemark L, Jonsson N, Persson B et al. (1999). Genes Chromosomes Cancer 26: 295-303.
20. Johnson TM, Rowe DE, Nelson BR, Swanson NA. (1992). J Am Acad Dermatol 26: 467-484.
21. Jonason AS, Kunala S, Price GJ, Restifo RJ, Spinelli HM, Persing JA et al. (1996). Proc Natl Acad Sci USA 93: 14025-14029.
22. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F et al. (1992). Science 258: 818-821.
23. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA et al. (1993). Carcinogenesis 14: 833-839.
24. Lesage D, Troussard X, Sola B. (2005). Int J Cancer 115: 171-176.
25. Ling G, Persson A, Berne B, Uhlen M, Lundeberg J, Ponten F. (2001). Am J Pathol 159: 1247-1253.
26. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM et al. (1991). Nature 350: 512-515.
27. Nakazawa H, English D, Randell PL, Nakazawa K, Martel N, Armstrong BK et al. (1994). Proc Natl Acad Sci USA 91: 360-364.
28. Oyama T, Kashiwabara K, Yoshimoto K, Arnold A, Koerner F. (1998). Cancer Res 58: 2876-2880.
29. Parangi S, O'Reilly M, Christofori G, Holmgren L, Grosfeld J, Folkman J et al. (1996). Proc Natl Acad Sci USA 93: 2002-2007.
30. Popp S, Waltering S, Herbst C, Moll I, Boukamp P. (2002). Int J Cancer 99: 352-360.
31. Popp S, Waltering S, Holtgreve-Grez H, Jauch A, Proby C, Leigh IM et al. (2000). J Invest Dermatol 115: 1095-1103.
32. Quinn AG, Sikkink S, Rees JL. (1994). Genes Chromosomes Cancer 11: 222-225.
33. Rehman I, Takata M, Wu YY, Rees JL. (1996). Oncogene 12: 2483-2490.
34. Ren ZP, Hedrum A, Ponten F, Nister M, Ahmadian A, Lundeberg J et al. (1996). Oncogene 12: 765-773.
35. Rotzer D, Krampert M, Sulyok S, Braun S, Stark H-J, Boukamp P et al. (2006). Oncogene in press.
36. Schoop VM, Mirancea N, Fusenig NE. (1999). J Invest Dermatol 112: 343-353.
37. Serrano M, Hannon GJ, Beach D. (1993). Nature 366: 704-707.
38. Sherr CJ, Roberts JM. (1999). Genes Dev 13: 1501-1512.
39. Shoker BS, Jarvis C, Davies MP, Iqbal M, Sibson DR, Sloane JP. (2001). Br J Cancer 84: 1064-1069.
40. Stark HJ, Willhauck MJ, Mirancea N, Boehnke K, Nord I, Breitkreutz D et al. (2004). Eur J Cell Biol 83: 631-645.
41. Utikal J, Udart M, Leiter U, Kaskel P, Peter RU, Krahn G. (2005a). Cancer Lett 219: 197-204.
42. Utikal J, Udart M, Leiter U, Peter RU, Krahn G. (2005b). Int J Oncol 26: 597-605.
43. Waring AJ, Takata M, Rehman I, Rees JL. (1996). Br J Cancer 73: 649-653.
44. Zahnow CA. (2002). Breast Cancer Res 4: 113-121.